Please login to the form below
Hetlioz
This page shows the latest Hetlioz news and features for those working in and with pharma, biotech and healthcare.
BMS' Opdivo backed as melanoma therapy in EU
Vanda Pharmaceuticals got the go-ahead for Hetlioz (tasimelteon) for the treatment of non-24-hour sleep wake disorder in totally blind adults - which was approved in the US last year -
Latest news
-
FDA approves sleep disorder drug for blind people
Vanda Pharmaceuticals wins backing for Hetlioz to improve a person’s body clock. ... This means Vanda was able to take advantage of a number of development incentives due to the orphan-drug designation for Hetlioz.
-
FDA panel backs sleep pattern drug for blind
Vanda’s Hetlioz intended to improve circadian rhythms in people who cannot see. ... A Food Drug and Administration (FDA) advisory committee voted unanimously to recommend approval of Vanda Pharmaceuticals' Hetlioz (tasimelteon) for non-24-hour disorder
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
-
Senior Copywriter
-
Salary TBC
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer opens AI-enabled drug discovery center in UK
- Roche reports continued growth in Q3, despite biosimilar competition
- Takeda offloads select portfolio to Acino ahead of Shire takeover
- The best in the UK healthcare system celebrated at QiC Diabetes awards 2019
- Merck wins CHMP recommendation for Ebola vaccine
- Roche scores another FDA approval for Xofluza
- CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal
- AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs
- A snapshot of Crescendo Biologics
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- A snapshot of Crescendo Biologics
- PME talks to CEO Theodora Harold...
- eyeforpharma Marketing and Customer Innovation Europe
- By Richard Springham...
- The Golden Goose
- Why it’s so hard for the US to curb runaway drug prices...
Quick links
Infographics
